VAERS reports by lot

GSK Hepatitis B lot 797F9: VAERS reports

35 VAERS reports list lot 797F9 as a GSK Hepatitis B vaccine, received between 2023-08-18 and 2024-11-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
0%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1019%
General / Systemic (non-local)815%
Neurological713%
Respiratory510%
Dermatological (non-injection-site)510%
Allergic / Anaphylactic48%
Gastrointestinal48%
Musculoskeletal48%
Cardiac / Cardiovascular24%
Psychiatric / Neuropsychiatric24%
Thrombotic / Hematological12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas8
Michigan4
California3
Pennsylvania2
Ohio2
Idaho2
North Carolina2
Oklahoma1
Colorado1
Florida1
Alabama1
Indiana1

Reports by month received

2023-083
2023-092
2023-107
2023-122
2024-011
2024-026
2024-031
2024-042
2024-051
2024-061
2024-071
2024-082
2024-093
2024-101
2024-112

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.